text.skipToContent text.skipToNavigation
You searched for "kinetic chromogenic"
Too many choices? Use the filter option on the left to narrow your product listing.
41-50 of 58 results
    SeaKem<sup class=reg>®</sup> GTG<sup class=reg>®</sup> Agarose
    Compare
    SeaKem® GTG® Agarose
    Catalog #: 50075

    SeaKem® GTG® Agarose, 1 kg, ensures reliable digestion and ligation of recovered DNA fragments.

    EA
    SeaKem<sup class=reg>®</sup> GTG<sup class=reg>®</sup> Agarose
    Compare
    SeaKem® GTG® Agarose
    Catalog #: 50071

    SeaKem® GTG® Agarose, 25 g, ensures reliable digestion and ligation of recovered DNA fragments.

    EA
    TheraPEAK<sup class=reg>®</sup> SfAAV<sup class=reg>®</sup> Medium
    Compare
    TheraPEAK® SfAAV® Medium
    Catalog #: BP12-945Q

    TheraPEAK® SfAAV® Medium for AAV production in SF9 cells, chemically defined, hydrolysate free, 1 L

    BOT
    SeaKem<sup class=reg>®</sup> Gold Agarose
    Compare
    SeaKem® Gold Agarose
    Catalog #: 50152

    SeaKem® Gold Agarose, 25 g, ideal for separation of large DNA fragments using low concentration gels or PFGE.

    EA
    SeaKem<sup class=reg>®</sup> Gold Agarose
    Compare
    SeaKem® Gold Agarose
    Catalog #: 50150

    SeaKem® Gold Agarose, 125 g, ideal for separation of large DNA fragments using low concentration gels or PFGE.

    EA
    D-HPBMC - Diseased Human Peripherial Blood Mononuclear Cells (Psoriasis)
    Compare
    D-HPBMC - Diseased Human Peripherial Blood Mononuclear Cells (Psoriasis)
    Catalog #: 00219738
    Limited Edition Peripherial Blood Mononuclear from Psoriasis Donor
    AMP
    P-HEK - Diseased Human Epidermal Keratinocytes (Non-Lesion)
    Compare
    P-HEK - Diseased Human Epidermal Keratinocytes (Non-Lesion)
    Catalog #: 00219735
    Limited Edition Epidermal Keratinocytes from Psoriasis Donor (Non-Lesion Site Derived)
    AMP
    P-HDF - Diseased Human Dermal Fibroblast (Lesion)
    Compare
    P-HDF - Diseased Human Dermal Fibroblast (Lesion)
    Catalog #: 00219736
    Limited Edition Dermal Fibroblasts from Psoriasis Donor (Lesion Site Derived)
    AMP
    TheraPEAK<sup class=reg>®</sup> LV Nucleocuvette<sup class=reg>®</sup> Cartridge, weldable (5 pcs)
    Compare
    TheraPEAK® LV Nucleocuvette® Cartridge, weldable (5 pcs)
    Catalog #: G4LN-7520W

    For use in combination with TheraPEAK® Nucleofector® Solution Sets, supporting the use of the 4D-Nucleofector®  LV Unit in a GMP environment.

    ST
    TheraPEAK<sup class=reg>®</sup> 4D-Nucleofector<sup class=reg>®</sup> LV Reservoirs, weldable (5 pcs)
    Compare
    TheraPEAK® 4D-Nucleofector® LV Reservoirs, weldable (5 pcs)
    Catalog #: G4LR-1501W
    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
    ST
1-10 of 1475 results
  • Inducible Cas9 T Cells: An Innovative Platform for Allogeneic CAR-T Cell Generation
    Poster on inducible Cas9 T Cells
  • Synthego_Lonza_Protocol_Genome Editing of Resting T cells
    Technical Protocol on Genome Editing of Resting T cells for associated White Paper "Genome Editing of Resting T cells"
  • Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T Cells
    Instructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
  • CAR T cells in Cancer Therapy
    A poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
  • PBMC Based T Cell Proliferation Assay
    Protocol instructions
  • Instructions for Use - Dendritic Cell (DC) and T Cell Assay from Matched PBMCs
    Protocol for DC and T Cell Assay from Matched PBMCs
  • Case Study – Improving the Expansion of Patients' T Cells
    In this serum-free media case study, learn how selection of memory T cells can aid in streamlining CAR-T therapies.
  • Large-scale editing of human T cells
    Watch Video
  • Synthego-Lonza Genome Editing of Resting T cells
    Case Study on Genome Editing of Resting T cells
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.